Organic anion-transporting polypeptides (Oatp) 1a1 and 1a4 were deleted by homologous recombination, and mice were characterized for Oatp expression in liver and kidney, transport in isolated hepatocytes, in vivo disposition of substrates, and urinary metabolomic profiles. Oatp1a1 and Oatp1a4 proteins were undetected in liver, and both lines were viable and fertile. Hepatic constitutive messenger RNAs (mRNAs) for Oatp1a4, 1b2, or 2b1 were unchanged in Oatp1a1 2/2 mice, whereas renal Oatp1a4 mRNA decreased approximately 50% (both sexes). In Oatp1a4 2/2 mice, no changes in constitutive mRNAs for other Oatps were observed. Uptake of estradiol-17b-D-glucuronide and estrone-3-sulfate in primary hepatocytes decreased 95 and 75%, respectively, in Oatp1a1 2/2 mice and by 60 and 30%, respectively, in Oatp1a4 2/2 mice. Taurocholate uptake decreased by 20 and 50% in Oatp1a1
mice, no changes in constitutive mRNAs for other Oatps were observed. Uptake of estradiol-17b-D-glucuronide and estrone-3-sulfate in primary hepatocytes decreased 95 and 75%, respectively, in Oatp1a1 2/2 mice and by 60 and 30%, respectively, in Oatp1a4 2/2 mice. Taurocholate uptake decreased by 20 and 50% in Oatp1a1
and Oatp1a4 2/2 mice, respectively, whereas digoxin was unaffected. Plasma area under the curve (AUC) for estradiol-17b-D-glucuronide increased 35 and 55% in male and female Oatp1a1 2/2 mice, respectively, with a concurrent 50% reduction in liver-to-plasma ratios. In contrast, plasma AUC or tissue concentrations of estradiol-17b-D-glucuronide were unchanged in Oatp1a4 2/2 mice. Plasma AUCs for dibromosulfophthalein increased nearly threefold in male Oatp1a1 2/2 and Oatp1a4 2/2 mice, increased by 40% in female Oatp1a4 2/2 mice, and were unchanged in female Oatp1a1 2/ 2 mice. In both lines, no changes in serum ALT, bilirubin, and cholesterol were noted. NMR analyses showed no generalized increase in urinary excretion of organic anions. However, urinary excretion of taurine decreased by 30-40% and was accompanied by increased excretion of isethionic acid, a taurine metabolite generated by intestinal bacteria, suggesting some perturbations in intestinal bacteria distribution. Key Words: knockout; uptake; metabolomic; xenobiotic transporters; biotransformation; toxicokinetics.
The organic anion-transporting polypeptides (Oatps) comprise a superfamily of solute carrier proteins (gene SLCO in humans or Slco in rodents) that function in the sodium-independent transport of a wide range of endogenous and exogenous compounds Meier, 2003, 2004) . To date, there are 11 known members of the transporter family in humans and 15 identified members in mice (Hagenbuch, 2007 (Hagenbuch, , 2010 Hagenbuch and Meier, 2004) . Oatps are major uptake transporters that are expressed in a variety of tissues including liver, kidney, gastrointestinal tract, and brain. In general, these transporters have relatively broad substrate specificity by which they contribute to the disposition of thyroid hormones (Hagenbuch, 2007) , steroid hormones and their conjugates (Kanai et al., 1996) , bile acids (Kullak-Ublick, 1999; Petzinger, 1994) , numerous drugs including digoxin, methotrexate, fexofenadine Meier, 2003, 2004) , and several toxicants including phalloidin and microcystin (Fisher et al., 2005; Meier-Abt et al., 2004) .
Animal models of transport deficiencies resulting from gene mutation or gene knockout studies have contributed to elucidating transporter function and defining their role in xenobiotic disposition . In this regard, several models of Oatp null mice have been characterized. The first such model was the targeted deletion of Oatp1b2 (Slco1b2), a transporter that is highly expressed in liver and orthologous to human OATP1B1 and OATP1B3 (Chen et al., 2008; Lu et al., 2008; Zaher et al., 2008) . These mice were phenotypically normal with the exception of increased serum bilirubin levels Zaher et al., 2008) . Additional research demonstrated that Oatp1b2 null mice were protected against phalloidinand microcystin-induced liver toxicity and showed altered plasma clearance and hepatic uptake of a variety of drug substrates (Chen et al. 2008; Zaher et al., 2008) .
One important observation made in characterizing transporter-deficient models is that there are frequently compensatory changes in expression of other transporters that contribute to the phenotype of the model. A classical example of such compensation is the transport deficient rat, a genetic mutant lacking functional Mrp2 (Abcc2) that is associated with a marked compensatory increase in Mrp3 (Abcc3) expression (Johnson et al., 2006; Ortiz et al., 1999) . In contrast, Mrp2 À/À mice show a compensatory increase in Mrp4 rather than Mrp3 (Chu et al., 2006) . In a similar manner, constitutive expression of Oatp1a4 increased in the Oatp1b2 À/À mouse Zaher et al., 2008) , although the functional impact of this change is unclear.
Recently, a mouse model in which Oatp1b2 along with four members of the mouse Oatp1a family (Oatp1a1, -1a4, -1a5, and -1a6) were concurrently deleted was reported (van de Steeg et al., 2010) . The strategy for such a broad gene deletion was to facilitate the interrogation of transporter function by minimizing the likelihood of compensatory restoration of function by an Oatp superfamily member with overlapping substrate specificity. These mice showed marked elevations in serum levels of conjugated bilirubin and unconjugated bile acids. Furthermore, hepatic uptake of methotrexate and fexofenadine was decreased leading to increased systemic exposure to both drugs.
The strategies employed to date to generate Oatp-deficient mouse models demonstrate that either single or multiple gene deletion approaches are useful for assessing transporter function. In the present work, functional and phenotypic alterations in mice lacking Oatp1a1 (Slco1a1) or Oatp1a4 (Slco1a4) were evaluated by studying the disposition of common substrates and urinary metabolomic profiling. The Oatps exhibit marked sex-dependent differences in hepatic expression in mice with Oatp1a1 being highly expressed in males, whereas hepatic Oatp1a4 is more abundant in females (Cheng et al., 2006) . It is hypothesized that loss of individual transporter function in these models will help to define their function in mice, including potential physiologic roles, and will provide relevant new data on the role of these transporters in xenobiotic disposition. , DNA spanning 385 base pairs starting with the ATG-containing exon (exons 4-6; Ogura et al., 2001 ) was deleted. In each case, the deleted DNA was replaced with an IRES-lacZ reporter and neomycin resistance cassette (IRES-lacZ-neo; Supplementary Fig. 1 ). For both lines, male chimeric mice were generated by injection of the targeted ES cells into C57Bl/6J blastocysts and bred with female C57Bl/6J mice to produce F1 heterozygotes. Germline transmission was confirmed (PCR analysis) after which F1 heterozygous males and females were mated to produce F2 wild-type, heterozygous, and homozygous null mutant animals.
MATERIALS AND METHODS
For the present experiments, homozygous null mice were backcrossed on the C57BL/6N background (Charles River, Raleigh, NC) and homozygous null mice representing those obtained after at least 10 generations of backcrossing on the C57Bl/6N background were used. Age-matched wild-type mice were obtained from Charles River. All animals were maintained in a temperaturecontrolled barrier facility with a 12-h light/dark cycle and allowed ad libitum access to water and rodent chow (Harlan Teklad 2018C).
Genotyping analyses. Purified DNA (tail snips) were used for PCR analysis (REDExtract-N-Amp Tissue PCR kit; Sigma). The primers for wild-type Oatp1a1 were 5#-AGAATGAGGACATAGTGGCATACAG-3# and 5#-AAAAGG-GACTGTCTCATGCTATATG-3#, and the knockout allele was detected with the neospecific primer 5#-GGGCCAGCTCATTCCTCCCACTCAT-3#. This strategy yielded fragments of 521 and 273 bp for the wild-type and null alleles, respectively. The primers for wild-type Oatp1a4 were 5#-CACAGAGATGA-GAAGAGGGTGTTGG-3#and 5#-GCAAGCATTTGTGGTAAACC TGAGC-3#, and the knockout allele was detected with the same neospecific primer noted above. This strategy yielded fragments of 232 and 476 bp for the wild-type and null alleles, respectively. Multiplex PCR was conducted on the digested neutralized genomic DNA with 500nM each of the primers for Oatp1a1 and Oatp1a4 genes. The amplification conditions were: 95°C for 7 min (Taq DNA polymerase activation) and 35 cycles of 96°C for 10 s (denaturing), 60°C for 30 s (annealing), and 68°C for 1 min 30 s (extension) followed by 7 min (68°C) at the end of the run. Amplification products were resolved on 1.4% agarose gels with ethidium bromide (40 min at 100 V).
Characterization of transporter expression in liver and kidney. Wildtype and null male and female mice (10-16 weeks of age) were anesthetized with ketamine/xylazine after which blood was collected to obtain serum for clinical chemistry analyses (see below). Liver and kidney were removed, flash frozen (liquid N 2 ) and stored frozen (approximately À70°C) pending analysis. Total RNA was isolated (Trizol Reagent; Invitrogen) after which RNA concentrations and purity were determined (ND1000 NanoDrop UV spectrophotometer; Thermo Scientific). RNA integrity was also confirmed by assessing the relative abundance of 18S and 28S ribosomal RNA (rRNA) by capillary gel electrophoresis (Agilent 2100 Bioanalyzer; Santa Clara, CA).
RNA (2 lg) was reverse transcribed to generate complementary DNA (cDNA) (High Capacity cDNA Reverse Transcription kit; Applied Biosystems, Foster City, CA). A negative control (no RT control) reaction, which lacked the reverse transcriptase enzyme, was run for each sample and used to monitor for genomic DNA amplification during the QPCR process. The cDNA and no RT controls were used as templates for QPCR. Standard curves for the target and endogenous control genes (18S rRNA) were generated with serial dilutions (0.001-60 ng per 20 ll reaction) of male or female mouse liver cDNA. Reactions were carried out with Power SYBR green PCR Master Mix (Applied Biosystems) and gene-specific probes (Table 1) in 384-well plates (Applied Biosystems 7900 HT Sequence Detection System with SDS 2.2 software).
Western blot analysis of Oatp1a1 and Oatp1a4. Liver (approximately 75-100 mg) was minced in 800 ll of ice-cold homogenizing buffer (0.25M sucrose, 10mM Tris-HCl at pH 7.5, containing 25 lg/ml leupeptin, 50 lg/ml aprotinin, 40 lg/ml PMSF, 0.5 lg/ml pepstatin, and 50 lg/ml antipain), then homogenized on ice, and subjected to centrifugation at 100,000 3 g for 1 h at 4°C. The resulting membrane pellet was resuspended in 0.25M sucrose, containing 10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 40 lg/ml PMSF. Protein concentrations were determined with the Bradford protein assay (Sigma) with bovine serum albumin as standard.
For electrophoretic separation, membrane proteins were mixed with sample loading buffer (75 lg protein/lane), separated on a 4-20% precast polyacrylamide gel (Beckman, Brea, CA), and transferred to a nitrocellulose membrane (1 h at 100 V at 4°C). Membranes were blocked for 1 h at room 588 GONG ET AL. temperature with 5% nonfat dry milk in Tris-buffered saline containing 0.1% Tween-20 (TBS-T) prior to incubation with Oatp antibodies. The Oatp1a1 antibody was raised in rabbits against the mouse Oatp1a1-specific peptide (NH2-CRKFHFPGDIHSPDTE-COOH) by Covance Research Products, Inc. (Berkeley, CA), and a polyclonal rabbit antimouse Oatp1a4 was purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Primary antibodies were diluted 1:200 with 5% nonfat milk in TBS-T and blots were incubated overnight at 4°C. After thorough washing, blots were incubated with goat antirabbit IgG horseradish peroxidase-linked secondary antibody (1:2000 dilution with 5% nonfat milk in TBS-T) for 1 h. Immunoreactive bands were detected with an enhanced chemical luminescence kit (Pierce Biotechnology Inc., Rockford, IL), and Oatp1a1 and 1a4 protein bands were visualized by exposure to Fuji Medical x-ray film.
In vitro hepatic uptake studies. Fresh mouse hepatocytes were isolated from male mice (20-35 g; 12-16 weeks of age) by a two-step collagenase perfusion method (Seglen, 1976) . Briefly, the liver was perfused at 37°C for 10 min with the following medium: 137mM NaCl, 5.4mM KCl, 0.5mM NaH 2 PO 4 , 0.42mM Na 2 HPO 4 , 10mM HEPES, 4.2mM NaHCO 3 , 0.5mM EGTA, 5mM glucose, equilibrated with 95% O 2 and 5% CO 2 . Collagenase, trypsin inhibitor, and calcium ion were added to 100 ml EGTA and glucose-free perfusate to give a final concentration of 0.05%, 0.005%, and 5mM, respectively. The liver was then perfused with the collagenase solution for an additional 7-10 min. After isolation, hepatocytes were suspended at 0°C in Krebs-Henseleit buffer supplemented with 12.5mM HEPES (pH 7.3).
To assess substrate uptake into hepatocytes, freshly isolated cells were suspended in Krebs-Henseleit buffer (1 million cells/ml) and preincubated for 3 min at 37°C. CSA was then added to the hepatocyte suspension to obtain a final concentration of 1lM. At the designated times (15 s and 1 min), an aliquot of the cell suspension (200 ll) was transferred into centrifuge tubes containing a top layer (100 ll) of silicone oil (density ¼ 1.015 g/ml) and a bottom layer (50 ll) of 3M potassium hydroxide (KOH). The tubes were then centrifuged at 10,000 3 g for 10 s at room temperature to drive the hepatocytes through the oil layer into the KOH solution. The tubes were kept overnight at room temperature to dissolve the hepatocytes, after which the centrifuge tube was cut (at the center of the oil layer) and contents transferred to scintillation vials. The radioactivity in both the buffer media compartment (i.e., top aqueous layer) and hepatocyte cell compartment (i.e., bottom aqueous layer) was determined by liquid scintillation counting. Hepatocyte protein was measured using a BCA protein assay kit (Pierce Biotechnology Inc.) and used for normalization of cellular uptake (dividing the uptake amount by protein content). The initial uptake rate was calculated from the uptake difference between 15 s and 1 min. Experiments were carried out with three separate hepatocyte preparations from each line with triplicate replicates in each assay.
In vivo pharmacokinetic studies. Wild-type and null male and female mice (10-16 weeks of age) were dosed intravenously (tail vein) with a bolus of [ 3 H]E2-17G (10 lCi/kg; 4 ml/kg) and exsanguinated from the abdominal vena cava under CO 2 anesthesia at 1, 2, 5, and 10 min after injection. Liver and kidney were also collected at these time points. Plasma concentrations of [ 3 H]E2-17G were determined by liquid scintillation counting (Tri-Carb 2910 TR; Perkin Elmer). Liver (approximately 100 mg aliquots) and kidney (entire left kidney) were minced and solubilized (Solvable; Perkin Elmer) prior to radiometric analysis.
In a separate experiment, DBSP (120 lmol/kg; 4 ml/kg) was administered by intravenous injection via the tail vein after which blood (approximately 10 ll) was collected from the infraorbital sinus at 2, 5, 10, and 30 min. Plasma concentrations of DBSP were determined spectrophotometrically after dilution in 0.1N NaOH as described by Lu et al. (2008) .
Clinical chemistry and histopathology. Clinical chemistry analyses were carried out according to standardized conditions (Advia 1800; Siemens, Deerfield, IL). A portion of the right medial lobe of the liver, the right kidney, and small intestine (duodenum, jejunum, and ileum) were collected from mice used in the transporter expression studies (outlined above) and fixed in neutral buffered formalin for histopathologic evaluation with hematoxylin and eosin.
Urinary NMR metabolomic profiling. Mice (n ¼ 5/sex/group of wild types and nulls) were allowed to acclimate to metabolism cages for a period of 48 h after which urine was collected for 24 h. All mice were approximately 9 
ALT (U/l) 43 ± 5 6 0 ± 12 46 ± 7 4 1 ± 14 56 ± 18 52 ± 10 AST (U/l) 161 ± 30 246 ± 48 137 ± 23 119 ± 23 299 ± 166 142 ± 20 Bilirubin (mg/dl) 0.11 ± 0.01 0.13 ± 0.02 0.12 ± 0.02 0.10 ± 0 0.13 ± 0.01 0.10 ± 0 Cholesterol (mg/dl) 102 ± 6 100 ± 8 104 ± 4 7 6 ± 3 7 4 ± 3 7 5 ± 4 Triglycerides (mg/dl) 81 ± 13 60 ± 10 79 ± 8 4 4 ± 4 4 6 ± 4 5 8 ± 5 BUN (mg/dl) 31 ± 3 2 1 ± 1 2 6 ± 3 2 3 ± 2 2 2 ± 4 1 9 ± 2 Note. Results represent the mean ± SE of 6-7 mice. months old and had been housed in the same room in the animal facility for a period of at least 4 months prior to collecting urine for metabolomic analyses. Published reports document that metabolomic variability in germ-free rats or those with defined intestinal flora is reduced over a period of 3-4 weeks, as urinary metabolites convert to those of otherwise normal rats (Nicholls et al., 2003; Rohde et al., 2007) . Therefore, although wild-type mice were obtained from a commercial vendor and homozygous Oatp null mice were from an internal breeding colony, housing in the same room for a period of 4 months under normal husbandry conditions should be sufficient to ensure complete acclimation and metabolic consistency between the mice and thereby eliminate a potential source of variability. During the urine collection period, mice had free access to food and water. Urine was collected in the presence of 0.1% Na azide at 4°C, and all samples were subjected to centrifugation to remove any particulates prior to freezing (À80°C) pending analysis. For NMR analysis, urine aliquots were thawed, mixed in a 2:1 ratio with 0.2N phosphate buffer in 20% D 2 O (pH 7.0) containing 0.1mM trimethylsilyl-2,2,3,3-tetradeuteropropionic acid (TSP), and transferred into NMR tubes. Samples were measured in a TCI 5 mm cryoprobe utilizing a 600 MHz Bruker NMR spectrometer (Bruker Biospin Corporation, Rheinstetten, Germany). Only the first sample was tuned and matched. A pulse sequence for water suppression was used, with the water signal at the carrier frequency, and gradient presaturation during the NOE mixing time of 50 ms and relaxation delay of 2 s. Other parameters were automatic 90°pulse length determination for each sample, identical receiver gain (for quantitative comparison), 256 scans, and measuring temperature of 300°K. Every sample was shimmed automatically. After acquisition, the spectra were automatically processed for phase and baseline correction as well as calibrated to 0 ppm on the TSP signal. Signals in the NMR spectra were identified and assigned to metabolites by comparison to spectral standards from public (Human Metabolome Database) and proprietary databases (Bbiorefcode Database; Bruker). Spectral regions representing well-defined signals with minimal overlap and good baseline were integrated (multiintegration function; Amix version 3.9.5; Bruker), and integrals were normalized to the total intensity of each spectrum, excluding the urea and water regions (6-4.6 ppm).
Data analysis. For plasma pharmacokinetic analyses, the linear trapezoidal rule was used to calculate the area under the curve (AUC) from the concentration versus time profile (t ¼ 0 to the last sampling point) for each mouse. All data, including the calculated AUCs, are reported as mean ± SE, and statistical significance was determined with Student's t-test or one-way analysis of variance followed by post hoc tests. Statistical significance was set at p < 0.05 (StatView; Abacus Concepts).
NMR data were subjected to principal component analysis (PCA), with males and females analyzed separately. Simple rectangular bins or buckets of 0.02 ppm width were created between 10 and 0.02 ppm as the sum of positive intensities within each bucket and scaled to the same reference region (10-0.02 ppm) with exclusion of the urea and water signals (6-4.6 ppm). PCA scores and loadings were calculated from the unscaled data (Partek Genomics Suite version 6.5; Partek Incorporated, St Louis, MO). The mean and SE of spectral region integrals for identified metabolites were calculated, and statistical significance relative to wild-type controls was determined with Student's t-test (p < 0.05). Urinary excretion of identified metabolites is reported semiquantitatively as fold change relative to wild-type mice. Figure 1A shows representative PCR analysis of heterozygous and homozygous genotypes for the Oatp1a1 À/À and Oatp1a4 À/À lines. In each case, there was no amplification of wild-type allele (521 and 232 base pair product, respectively), confirming the null genotype. The Oatp proteins were also undetected in liver of homozygote nulls compared with wildtype C57BL/6N mice (Fig. 1B) . Specifically, no Oatp1a1 was detected in liver from males in the Oatp1a1 À/À line, and no Oatp1a4 was detected in homozygous null females from the Oatp1a4 À/À line, even when as much as 200 lg protein was analyzed. Both mouse lines developed normally and homozygous nulls bred efficiently. Clinical chemistry analyses,
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FIG. 2.
Hepatic expression of Oatp1a1, 1a4, 1b2, and 2b1 mRNAs in male and female mice. In wild-type mice (C57BL/6N), Oatp1a1 was highly expressed in males, Oatp1a4 was more abundant in females, and no sex differences were noted for Oatb1b2 or 2b1. Other than the loss of the targeted knockout, no significant differences in hepatic Oatp mRNA levels were noted in the Oatp1a1 À/À and Oatp1a4 À/À lines. Results are presented as the mean ± SE of 6-7 animals.
FIG. 1.
Evidence for lack of expression of Oatp1a1 and Oatp1a4 in null mouse models. The PCR genotyping strategy (A) yielded products of 521 and 273 base pairs (Oatp1a1) and 232 and 476 base pairs (Oatp1a4) for the wildtype and null alleles, respectively. Evaluation of heterozygous mice showed the presence of both alleles with loss of the wild-type allele in each null model. Hepatic levels of Oatp protein were evaluated by immunoblotting (B), with no evidence of Oatp1a1 noted in male mice and no detectable Oatp1a4 in female mice.
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conducted as a first-tier phenotypic characterization of Oatp1a1 À/À and Oatp1a4 À/À mice, showed no evidence of hepatotoxicity, no changes in serum bilirubin levels, no effects on hepatic or renal function (Table 2) , and no histopathologic changes were observed in liver, kidney, or small intestine of young adult mice (results not shown).
Messenger RNA (mRNA) levels for numerous transporters were evaluated in the liver and kidney of null mice. In Oatp1a1 À/À mice, the complete absence of Oatp1a1 was not associated with any major change in the expression of other hepatic Oatps (Fig. 2) . Similarly, in Oatp1a4 À/À mice, no difference in Oatp expression was observed in liver. In the kidney, Oatp1a4 mRNA decreased by about 50% relative to wild types in Oatp1a1 À/À males and females (Fig. 3) . Hepatic and renal mRNA levels for other transporters located on basolateral membranes, including Oct1 (Scl22a1) and Mrp3 (Abcc3) were unchanged. Other major hepatic transporters expressed on canalicular membranes, including Mdr1a (Abca1), Mrp2 (Abcc2), and Bcrp (Abcg2) were unchanged in either null mouse line (results not shown).
Studies to evaluate alterations in transporter functions in the null mice were carried out in vitro with primary hepatocytes from male mice. The uptake of E2-17G and E3S was reduced by 95 and 75%, respectively, in hepatocytes from male Oatp1a1 À/À mice (Fig. 4) . Hepatic uptake of these two substrates was also reduced in male Oatp1a4 À/À mice, albeit to a somewhat lesser extent than that observed in Oatp1a1 À/À mice (60 and 30% for E2-17G and E3S, respectively). The uptake of taurocholate was significantly reduced in both lines, with a greater reduction noted in the Oatp1a4 À/À mice (approximately 20 and 50% in Oatp1a1 À/À and Oatp1a4 À/À mice, respectively), whereas uptake of digoxin did not differ from wild-type mice. As expected, the uptake of MPP, an organic cation, and CSA, which diffuses passively into hepatocytes, was unaffected.
FIG. 4. Uptake of various transporter substrates in primary hepatocytes isolated from male Oatp1a1
À/À and Oatp1a4 À/À mice. Hepatocytes (in suspension)
were incubated with designated radioactive substrates (1 lM), and initial uptake rate was calculated from differences in radioactivity content between 15 s and 1 min. The uptake of E2-17G and E3S was reduced in both lines, with a greater deficit observed in the Oatp1a1 À/À line. The uptake of taurocholate (TC) was also reduced, with a greater deficit observed in the Oatp1a4 À/À line. No difference in uptake was observed with digoxin, MPP, and CSA. Results are presented as the mean ± SE of three separate hepatocyte experiments and * denotes statistical significance from wild type (p < 0.05). For E2-17G, E3S, and TC, uptake in Oatp1a1 À/À mice was also statistically different from that observed in hepatocytes from Oatp1a4 À/À mice.
FIG. 3.
Renal expression of Oatp1a1, 1a4, and 2b1 mRNAs in male and female mice. In wild-type mice (C57BL/6N), Oatp1a1 was highly expressed in males, and below detection in females, and no sex differences were noted for Oatb1a4 or 2b1. In Oatp1a1 À/À mice, renal mRNA levels of Oatp1a4 were decreased (both sexes), whereas no significant differences in renal Oatp mRNA levels were noted in Oatp1a4 À/À mice. Results are presented as the mean ± SE of 6-7 animals.
CHARACTERIZATION OF OATP1A1 AND OATP1A4 NULL MICE
Functional studies were extended to in vivo analysis of plasma pharmacokinetics of E2-17G and DBSP in each line and sex. E2-17G was rapidly cleared from plasma after intravenous injection in wild-type mice, and although still rapidly cleared in the Oatp1a1 À/À mice, plasma concentrations were at least 50% higher than wild-type mice at 1 and 2 min after injection in males and up to 5 min in females (Fig. 5) . The overall change in plasma concentrations corresponded to an increase in plasma AUC of approximately 35 and 55%, respectively, in Oatp1a1 À/À male and female mice (Table 3 ). In contrast, plasma concentrations of E2-17G equivalents were unchanged in male and female Oatp1a4 À/À mice relative to that observed in wild-type mice (Fig. 5 , Table 3 ).
In concert with the increased plasma AUC, liver-to-plasma (L/ P) ratios decreased by approximately 50% in male and female Oatp1a1 À/À mice (at 2 min after injection; Table 3 ). Kidney-toplasma (K/P) ratios were also decreased by about 45 and 30%, respectively, in male and female Oatp1a1 À/À mice. In contrast, L/ P ratios for E2-17G were unchanged in Oatp1a4 À/À mice, with the only a small decrease in the K/P ratio for E2-17G in female , and Oatp1a1 À/À mice. Plasma levels were about 50% higher than wild types in male and female Oatp1a1 À/À mice at the early time points, whereas plasma concentrations in Oatp1a4 À/À mice were not different than wild types. Results are presented as the mean ± SE of 5-6 mice, and *denotes statistical significance from wild type (p < 0.05).
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Oatp1a4
À/À mice. At 5 min after dosing, hepatic concentrations of E2-17G continued to increase, reaching an L/P ratio of nearly 10 in wild types, and L/P ratios in Oatp1a1 À/À mice remained approximately 50% lower (results not shown). In contrast, K/P ratios of E2-17G did not increase between the 2-and 5-min time points in wild-type or null mice.
The plasma elimination of DBSP differed from that of E2-17G in that plasma concentrations of DBSP were higher in males from both Oatp1a1
À/À and Oatp1a4 À/À lines than those observed in wild types throughout the 30-min time course (Fig. 6) . Plasma AUCs increased threefold in male null mice (4.9, 15.4, and 16.6mMÁh for wild type, Oatp1a1 À/À , and Oatp1a4 À/À lines, respectively). The plasma AUC for DBSP was higher in wildtype females than males, but only female Oatp1a4 À/À mice showed higher plasma concentrations over the time course. The plasma AUC increased by approximately 40% in female Oatp1a4 À/À relative to wild-type mice (17.8 and 24.7mMÁh, respectively).
Urinary NMR profiling was carried out to determine whether altered Oatp transport function affected systemic organic anion excretion or revealed other phenotypic changes. Mice used in this work were approximately 9 months of age to allow for complete acclimation between the wild-type and Oatp null mice and thereby eliminate any potential environmental source of variability. Metabolomic profiles from male and female mice were analyzed separately because the excretion of trimethylamine (TMA) and trimethylamine-N-oxide (TMAO) was markedly different (TMA predominant in males; TMAO predominant in females) and dominated any comparison between the sexes (results not shown). The PCA scores plot (Fig. 7) , showed clear separation between wild-type and Oatp1a1 À/À and Oatp1a4 À/À mice, with approximately 70% of the variance accounted for by the first two PCs. There was some variability noted in the groups, particularly for the Oatp1a1 À/À males, where one mouse excreted very high levels of citrate and hippurate. There was also more obvious separation between wild-type and Oatp1a1 À/À males and wild-type and Oatp1a4 À/À females. The Oatp1a1 À/À and Oatp1a4 À/À mice also separated from each other by PCA analyses (Supplementary fig. 2 ), with a more substantial separation between the males. Urinary metabolites that were statistically different from wild types are noted in Table 4 . Overall, there was no evidence for a generalized increase in the excretion of organic anions in Oatp null mice. However, the urinary excretion of taurine decreased by 30-40% in male and female Oatp1a1 À/À and female Oatp1a4 À/À mice, and this change was accompanied by an increase in the excretion of isethionic acid (2-hydroxyethanesulfonic acid), the deaminated metabolite of taurine in all Oatp null mice. Male Oatp1a1 À/À and Oatp1a4 À/À mice excreted less TMA and female Oatp1a4 À/À mice excreted less TMA and TMAO than wild types, whereas neither metabolite was affected in female Oatp1a1 À/À mice. Additionally, gulonic acid excretion decreased in males (both lines), whereas females (both lines) excreted less indoxylsulfate, acetic acid, and lactate than wild types. Female Oatp1a1 À/À and Oatp1a4 À/À mice also excreted more niacinamide and N-methylnicotinamide along with several ketoacids resulting from metabolism of branched chain amino acids (2-oxoisovaleric acid, 3-methyl-2-oxovaleric acid, and 2-oxoisocaproic acid), with no changes observed in these metabolites in males.
DISCUSSION
It is widely recognized that uptake and efflux of endogenous substances and xenobiotics are important determinants of their disposition and physiologic, pharmacologic, or toxicologic activities. To this end, gene deletion models for numerous xenobiotic transporters have been developed, and the utility of these models has been demonstrated by assessing functional , and Oatp1a4 À/À mice. DBSP (120 lmol/kg; 4 ml/kg) was injected intravenously, and plasma levels were determined for up to 30 min after injection. Plasma levels of DBSP were higher than wild types in Oatp1a1
and Oatp1a4 À/À male mice and female Oatp1a4 À/À mice at all time points (p < 0.05).
CHARACTERIZATION OF OATP1A1 AND OATP1A4 NULL MICE attributes including alterations in drug pharmacokinetics, toxicologic effects, and constitutive changes in endogenous substrates . Transporter deficient models are generally viable and fertile, suggesting that their absence is not incompatible with life or that there is some redundancy or physiological compensation that restores normal function (Chen et al., 2008; Jonker et al. 2003; Lu et al., 2008; Sweet et al., 2002; van de Steeg et al., 2010; Zaher et al., 2008) . The present work adds to the body of literature on gene deletion models of altered transport function relative to Oatp1a1 and Oatp1a4 function in mice. The results indicated that no significant compensatory changes were noted in hepatic or renal expression of other Oatps. Recent data also demonstrated that constitutive expression of transporters was unaltered in the cerebral cortex of Oatp1a4 À/À mice (Ose et al., 2010) , confirming the general lack of altered expression of other transporters in these mice.
Functional deficits were observed in the mice, with the most obvious effects noted in male Oatp1a1 À/À mice. Results from various expression systems indicate that anionic estrogen conjugates are substrates for mouse Oatp1a1, 1a4, and 1b2 Meyer zu Schwabedissen et al., 2009; van Montfoort et al., 2002) . Therefore, the marked reduction in uptake of E2-17G in hepatocytes from male Oatp1a1 À/À mice is likely to result from elimination of the normally high constitutive levels of this protein. This work was extended to in vivo studies, wherein peak plasma levels of E2-17G increased by approximately 50% in male and female Oatp1a1 À/À mice, with a concomitant increase in plasma AUC and a decrease in L/P and K/P ratios for E2-17G. In contrast, these dispositional parameters were essentially unchanged in Oatp1a4 À/À mice. These results suggest that Oatp1a1 is likely to contribute to the in vivo clearance of E2-17G, although other transporters as well as metabolism contribute to its clearance from plasma.
Bromosulfophthalein is a substrate for mouse Oatp1a4 (van Montfoort et al., 2002) . The uptake of the nonmetabolizable DBSP was not evaluated in vitro, but in vivo, the plasma AUC for DBSP increased in both male and female Oatp1a4 À/À mice, a result consistent with a role for Oatp1a4 in the transport of DBSP. In contrast, only male Oatp1a1 À/À mice showed any change in plasma DBSP levels, suggesting that this transporter may contribute in vivo. The disposition of DBSP is also altered in Oatp1b2 À/À mice , suggesting that other Oatps can contribute to its removal from the plasma compartment.
Based on standard clinical chemistry parameters, Oatp1a1
and 1a4 À/À mice were not distinguished from wild types. Previous reports have shown increased serum bilirubin in Oatp1b2 À/À and Slco1a/1b À/À mice, with changes of 2-to 40-fold, respectively van de Steeg et al., 2010) . The lack of alterations in serum bilirubin levels in either Oatp1a1
or Oatp1a4 À/À mice indicates that the loss of either one of these transporters is not sufficient to alter bilirubin levels.
Urinary metabolomic profiling was used in the present work to further probe potential functional deficits or phenotypic alterations in Oatp1a1 À/À and Oatp1a4 À/À mice. Although the null mice were discriminated from age-matched wild types by PCA, there was no evidence for a generalized increase in organic anion excretion, suggesting that redundancy in Oatp function or other organic anion transporters may compensate for the loss of Oatp1a1 or Oatp1a4. This observation is also consistent with the lack of any frank changes in clinical chemistry or major organ pathology in these mice.
Some variability in the urinary metabolite profiles of the Oatp nulls was attributed to differences in the excretion of predominant metabolites including citrate and hippurate. Whereas these metabolites may contribute to separation by PCA, the major metabolite that differentiated Oatp null mice from wild types was taurine. Taurine is routinely detected in urine by NMR analyses, and numerous studies have reported that its excretion is increased by hepatotoxicants, particularly in rats (Robertson, 2005) . In mice, taurine excretion is increased after c-radiation (Tyburski et al., 2008) , whereas alcohol-induced liver injury decreases its urinary excretion (Bradford et al., 2008) . Although toxicity-induced changes in taurine excretion may be associated with perturbations in cysteine metabolism (Brosnan and Brosnan, 2006) , decreased excretion of taurine in Oatp null mice was accompanied by increased excretion of isethionic acid, a taurine metabolite that is generated by intestinal bacteria (Fellman et al., 1980; Krejcik et al., 2010) . Therefore, it is possible that the observed changes in taurine and isethionic acid may result from alterations in resident intestinal flora rather than an effect on sulfur-containing amino acid metabolism. In this regard, preliminary data suggest that there are marked changes in Bacteroides and Firmicutes species in the intestine of male Oatp1a1 À/À mice (Limaye et al., 2011) . Changes in the distribution or numbers of bacterial species in the Oatp null mice may also contribute to altered excretion of other bacterialgenerated metabolites including decreased excretion of TMA and TMAO (al-Waiz et al., 1992) as was observed in the present evaluations. Additional studies are presently being directed to fully characterize the intestinal bacteria in these mice.
The first Oatp to be evaluated in a null model was Oatp1b2 because this liver-specific protein is the murine homologue of Data represent the mean fold change relative to male or female wild-type mice (n ¼ 5/sex) with p < 0.05 based on integrated spectra. Identified metabolites that were unchanged in the urine of both males and females included hippurate, allantoin, glucose, ascorbic acid, creatine, and dimethylamine. CHARACTERIZATION OF OATP1A1 AND OATP1A4 NULL MICE human OATP1B1 and OATP1B3 (Cattori et al., 2000; Ogura et al., 2000) . In contrast, there are no human homologues of mouse Oatp1a1 and 1a4 , which may raise some question on the overall relevance of the present findings to humans. However, as mice are widely used in metabolism, toxicity, and carcinogenicity studies, these models are useful for understanding how transporter deletions modulate xenobiotic disposition, toxicity, and phenotype. As such they provide important clues for probing the fate of drugs and chemicals in humans and facilitate the assessment of mechanisms of toxicity that can inform and improve human risk assessment.
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